To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.
Clinical trial NCT00151502 · COMPLETED
Trial details
- NCT number
- NCT00151502
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-11-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.